Market Cap (In CNY)
6.41 Billion
Revenue (In CNY)
496.11 Million
Net Income (In CNY)
17.55 Million
Avg. Volume
4.91 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 7.06-16.1
- PE
- 316.8
- EPS
- 0.05
- Beta Value
- 0.613
- ISIN
- CNE1000051H8
- CUSIP
- -
- CIK
- -
- Shares
- 405185000.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Shaowen Fan
- Employee Count
- -
- Website
- https://www.olymvax.com
- Ipo Date
- 2021-06-08
- Details
- Olymvax Biopharmaceuticals Inc. develops and supplies vaccines. The company offers vaccines for Tetanus, a deadly infectious disease that causes nervous system toxicity by toxigenic clostridium tetanus; and haemophilus influenzae type b. it also develops vaccines for Staphylococcus aureus, a pathogenic bacterium that causes hospital infection and community infection; and Group A streptococcus disease. The company was founded in 2009 and is based in Chengdu, China.
More Stocks
-
AQUEF
-
MHC-U
-
601518Jilin Expressway Co., Ltd.
601518
-
ASPI
-
LVVV
-
AEXFFAminex PLC
AEXFF
-
JETMF
-
UCBJYUCB SA
UCBJY